Page 38 - Read Online

Page 14 of 14 Xu et al. Cancer Drug Resist 2024;7:13 https://dx.doi.org/10.20517/cdr.2023.141

100. Xu Y, Zhao J, Gao C, et al. Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1
pathway. Cell Signal 2021;86:110095. DOI PubMed
101. Gao C, Xu Y, J Qi L, Bao YF, Zhang L, Zheng L. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and
multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis. Cell Biol Toxicol 2022;38:825-
45. DOI PubMed
102. Fu X, Sun G, Tu S, et al. Hsa_circ_0046523 mediates an immunosuppressive tumor microenvironment by regulating MiR-148a-3p/
PD-L1 axis in pancreatic cancer. Front Oncol 2022;12:877376. DOI PubMed PMC
103. Yang Z, Chen W, Wang Y, Qin M, Ji Y. CircKRT1 drives tumor progression and immune evasion in oral squamous cell carcinoma
by sponging miR-495-3p to regulate PDL1 expression. Cell Biol Int 2021;45:1423-35. DOI PubMed
104. Luo Y, Tang W, Xiang S, Feng J, Zu X. Non-coding RNAs in breast cancer: implications for programmed cell death. Cancer Lett
2022;550:215929. DOI PubMed
105. Zheng Y, Ren S, Zhang Y, et al. Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage
polarization and tumor immune escape via regulating the expression and secretion of IL-4. Cancer Cell Int 2022;22:264. DOI
PubMed PMC
106. Lu C, Shi W, Hu W, et al. Endoplasmic reticulum stress promotes breast cancer cells to release exosomes circ_0001142 and induces
M2 polarization of macrophages to regulate tumor progression. Pharmacol Res 2022;177:106098. DOI PubMed
107. Huang X, Song C, Zhang J, Zhu L, Tang H. Circular RNAs in breast cancer diagnosis, treatment and prognosis. Oncol Res
2024;32:241-9. DOI PubMed PMC
108. Wang B, Chen H, Deng Y, et al. CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6
expression and activating the MAPK signaling pathway. J Transl Med 2023;21:186. DOI PubMed PMC
109. Liu Y, Liu Y, He Y, et al. Hypoxia-induced FUS-circTBC1D14 stress granules promote autophagy in TNBC. Adv Sci
2023;10:2204988. DOI PubMed PMC
110. Darbeheshti F, Mansoori Y, Azizi-tabesh G, et al. Evaluation of circ_0000977-mediated regulatory network in breast cancer: a
potential discriminative biomarker for triple-negative tumors. Biochem Genet 2023;61:1487-508. DOI PubMed
111. Darbeheshti F, Zokaei E, Mansoori Y, et al. Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast
cancer: a potential regulator of GATA3. Cancer Cell Int 2021;21:312. DOI PubMed PMC
112. Zheng X, Huang M, Xing L, et al. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and
development of triple-negative breast cancer. Mol Cancer 2020;19:73. DOI PubMed PMC
113. Yu J, Shen W, Xu J, Gong B, Gao B, Zhu J. circUSP42 is downregulated in triple-negative breast cancer and associated with poor
prognosis. Technol Cancer Res Treat 2020;19:153303382095082. DOI PubMed PMC
114. Liu P, Zou Y, Li X, et al. circGNB1 facilitates triple-negative breast cancer progression by regulating miR-141-5p-IGF1R axis. Front
Genet 2020;11:193. DOI PubMed PMC
115. Li Y, Shi P, Zheng T, Ying Z, Jiang D. Circular RNA hsa_circ_0131242 promotes triple-negative breast cancer progression by
sponging hsa-miR-2682. Onco Targets Ther 2020;13:4791-8. DOI PubMed PMC
116. Zou Y, Zheng S, Xiao W, et al. circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through
regulating IGF1 and FGF2 expression. Carcinogenesis 2019;40:1469-79. DOI PubMed
117. Xu J, Shao C, Wang X, et al. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3
axis. Cell Death Dis 2019;10:175. DOI PubMed PMC
118. Zhang J, Xu HD, Xing XJ, Liang ZT, Xia ZH, Zhao Y. CircRNA_069718 promotes cell proliferation and invasion in triple-negative
breast cancer by activating Wnt/β-catenin pathway. Eur Rev Med Pharmacol Sci 2019;23:5315-22. DOI PubMed
119. Xiao W, Zheng S, Zou Y, et al. CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating
miR-421 and RASA1. Aging 2019;11:12043-56. DOI PubMed PMC
120. Wang ST, Liu LB, Li XM, et al. Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway.
Neoplasma 2019;66:232-9. DOI PubMed
121. Tang H, Huang X, Wang J, et al. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative
breast cancer. Mol Cancer 2019;18:23. DOI PubMed PMC
122. Zeng K, He B, Yang BB, et al. The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer 2018;17:160. DOI PubMed
PMC
123. He R, Liu P, Xie X, et al. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin
Cancer Res 2017;36:145. DOI PubMed PMC
124. Magalhães L, Ribeiro-dos-santos AM, Cruz RL, et al. Triple-negative breast cancer circRNAome reveals Hsa_circ_0072309 as a
potential risk biomarker. Cancers 2022;14:3280. DOI PubMed PMC